Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency

S. Corti, A. Bordoni, D. Ronchi, O. Musumeci, M. Aguennouz, A. Toscano, C. Lamperti, N. Bresolin, G. P. Comi

Research output: Contribution to journalArticle

Abstract

Carnitine palmitoyltransferase II (CPT II) deficiency is the most common inherited disorder of lipid metabolism characterized in its adult form by attacks of myalgia and myoglobinuria. We analyzed a cohort of 22 CPT II-deficient patients (representing 20 independent probands) to correlate clinical presentation and molecular data. The common p.Ser113Leu mutation was detected with an allelic frequency of 67.5% (27/40), in association with mild adult-onset phenotype. In addition to the p.Ser113Leu mutation, other 10 disease-causing mutations were identified, 5 of which were novel. They are a micro-insertion within exon 5, three aminoacid substitutions within the coding region, namely p.Arg151Trp, p.Asp576Gly, p.Arg247Trp and a truncating stop codon mutation (p.Arg554Ter). Our data expand the spectrum of CPT II mutations and help to evaluate possible correlations between genotypes and phenotypes.

Original languageEnglish
Pages (from-to)97-103
Number of pages7
JournalJournal of the Neurological Sciences
Volume266
Issue number1-2
DOIs
Publication statusPublished - Mar 15 2008

Fingerprint

Carnitine O-Palmitoyltransferase
Mutation
Lipid Metabolism Disorders
Myoglobinuria
Terminator Codon
Myalgia
Genetic Association Studies
Exons
Phenotype

Keywords

  • Carnitine palmitoyltransferase II
  • CPT2
  • Fatty acid oxidation
  • Genotype-phenotype
  • Mutation
  • Skeletal muscle

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency. / Corti, S.; Bordoni, A.; Ronchi, D.; Musumeci, O.; Aguennouz, M.; Toscano, A.; Lamperti, C.; Bresolin, N.; Comi, G. P.

In: Journal of the Neurological Sciences, Vol. 266, No. 1-2, 15.03.2008, p. 97-103.

Research output: Contribution to journalArticle

@article{ead07020cc0c48349752804af6e7d534,
title = "Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency",
abstract = "Carnitine palmitoyltransferase II (CPT II) deficiency is the most common inherited disorder of lipid metabolism characterized in its adult form by attacks of myalgia and myoglobinuria. We analyzed a cohort of 22 CPT II-deficient patients (representing 20 independent probands) to correlate clinical presentation and molecular data. The common p.Ser113Leu mutation was detected with an allelic frequency of 67.5{\%} (27/40), in association with mild adult-onset phenotype. In addition to the p.Ser113Leu mutation, other 10 disease-causing mutations were identified, 5 of which were novel. They are a micro-insertion within exon 5, three aminoacid substitutions within the coding region, namely p.Arg151Trp, p.Asp576Gly, p.Arg247Trp and a truncating stop codon mutation (p.Arg554Ter). Our data expand the spectrum of CPT II mutations and help to evaluate possible correlations between genotypes and phenotypes.",
keywords = "Carnitine palmitoyltransferase II, CPT2, Fatty acid oxidation, Genotype-phenotype, Mutation, Skeletal muscle",
author = "S. Corti and A. Bordoni and D. Ronchi and O. Musumeci and M. Aguennouz and A. Toscano and C. Lamperti and N. Bresolin and Comi, {G. P.}",
year = "2008",
month = "3",
day = "15",
doi = "10.1016/j.jns.2007.09.015",
language = "English",
volume = "266",
pages = "97--103",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency

AU - Corti, S.

AU - Bordoni, A.

AU - Ronchi, D.

AU - Musumeci, O.

AU - Aguennouz, M.

AU - Toscano, A.

AU - Lamperti, C.

AU - Bresolin, N.

AU - Comi, G. P.

PY - 2008/3/15

Y1 - 2008/3/15

N2 - Carnitine palmitoyltransferase II (CPT II) deficiency is the most common inherited disorder of lipid metabolism characterized in its adult form by attacks of myalgia and myoglobinuria. We analyzed a cohort of 22 CPT II-deficient patients (representing 20 independent probands) to correlate clinical presentation and molecular data. The common p.Ser113Leu mutation was detected with an allelic frequency of 67.5% (27/40), in association with mild adult-onset phenotype. In addition to the p.Ser113Leu mutation, other 10 disease-causing mutations were identified, 5 of which were novel. They are a micro-insertion within exon 5, three aminoacid substitutions within the coding region, namely p.Arg151Trp, p.Asp576Gly, p.Arg247Trp and a truncating stop codon mutation (p.Arg554Ter). Our data expand the spectrum of CPT II mutations and help to evaluate possible correlations between genotypes and phenotypes.

AB - Carnitine palmitoyltransferase II (CPT II) deficiency is the most common inherited disorder of lipid metabolism characterized in its adult form by attacks of myalgia and myoglobinuria. We analyzed a cohort of 22 CPT II-deficient patients (representing 20 independent probands) to correlate clinical presentation and molecular data. The common p.Ser113Leu mutation was detected with an allelic frequency of 67.5% (27/40), in association with mild adult-onset phenotype. In addition to the p.Ser113Leu mutation, other 10 disease-causing mutations were identified, 5 of which were novel. They are a micro-insertion within exon 5, three aminoacid substitutions within the coding region, namely p.Arg151Trp, p.Asp576Gly, p.Arg247Trp and a truncating stop codon mutation (p.Arg554Ter). Our data expand the spectrum of CPT II mutations and help to evaluate possible correlations between genotypes and phenotypes.

KW - Carnitine palmitoyltransferase II

KW - CPT2

KW - Fatty acid oxidation

KW - Genotype-phenotype

KW - Mutation

KW - Skeletal muscle

UR - http://www.scopus.com/inward/record.url?scp=38849097724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849097724&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2007.09.015

DO - 10.1016/j.jns.2007.09.015

M3 - Article

C2 - 17936304

AN - SCOPUS:38849097724

VL - 266

SP - 97

EP - 103

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -